• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国创伤后相关肢体骨髓炎的流行病学更新:一项 10 年多中心队列研究。

Epidemiological updates of post-traumatic related limb osteomyelitis in china: a 10 years multicentre cohort study.

机构信息

Department of Orthopaedics, Second Affiliated Hospital of Chongqing Medical University.

Department of Orthopaedics, Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY.

出版信息

Int J Surg. 2023 Sep 1;109(9):2721-2731. doi: 10.1097/JS9.0000000000000502.

DOI:10.1097/JS9.0000000000000502
PMID:37247014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10498838/
Abstract

BACKGROUND

Post-traumatic related limb osteomyelitis (PTRLO) is a complex bone infection. Currently, there are no available microbial data on a national scale that can guide appropriate antibiotic selection, and explore the dynamic changes in dominant pathogens over time. This study aimed to conduct a comprehensive epidemiological analysis of PTRLO in China.

METHODS

The study was approved by the Institutional Research Board (IRB), and 3526 PTRLO patients were identified from 212 394 traumatic limb fracture patients at 21 hospitals between 1 January 2008 and 31 December 2017. A retrospective analysis was conducted to investigate the epidemiology of PTRLO, including changes in infection rate (IR), pathogens, infection risk factors and antibiotic resistance and sensitivity.

RESULTS

The IR of PTRLO increased gradually from 0.93 to 2.16% (Z=14.392, P <0.001). Monomicrobial infection (82.6%) was significantly higher than polymicrobial infection (17.4%) ( P <0.001). The IR of Gram-positive (GP) and Gram-negative (GN) pathogens showed a significant increase from the lowest 0.41% to the highest 1.15% (GP) or 1.62% (GN), respectively. However, the longitudinal trend of GP vs. GN's composition did not show any significance (Z=±1.1918, P >0.05). The most prevalent GP strains were Methicillin-sensitive Staphylococcus aureus (MSSA) (17.03%), Methicillin-resistant Staphylococcus aureus (MRSA) (10.46%), E. faecalis (5.19%) and S. epidermidis (4.87%). In contrast, the dominant strains GN strains were Pseudomonas Aeruginosa (10.92%), E. cloacae (10.34%), E. coli (9.47%), Acinetobacter Baumannii (7.92%) and Klebsiella Pneumoniae (3.33%). In general, the high-risk factors for polymicrobial infection include opened-fracture (odds ratio, 2.223), hypoproteinemia (odds ratio, 2.328), and multiple fractures (odds ratio, 1.465). It is important to note that the antibiotics resistance and sensitivity analysis of the pathogens may be influenced by complications or comorbidities.

CONCLUSIONS

This study provides the latest data of PTRLO in China and offers trustworthy guidelines for clinical practice. (China Clinical Trials.gov number, ChiCTR1800017597).

摘要

背景

创伤后相关肢体骨髓炎(PTRLO)是一种复杂的骨感染。目前,在全国范围内,没有可用于指导抗生素选择的微生物数据,也无法了解优势病原体随时间的动态变化。本研究旨在对中国的 PTRLO 进行全面的流行病学分析。

方法

该研究得到了机构审查委员会(IRB)的批准,对 2008 年 1 月 1 日至 2017 年 12 月 31 日期间,21 家医院的 212394 例创伤性肢体骨折患者中,确定了 3526 例 PTRLO 患者。对 PTRLO 的流行病学进行回顾性分析,包括感染率(IR)、病原体、感染危险因素和抗生素耐药性及敏感性的变化。

结果

PTRLO 的 IR 从 0.93%逐渐升高到 2.16%(Z=14.392,P<0.001)。单一致病菌感染(82.6%)明显高于多致病菌感染(17.4%)(P<0.001)。革兰氏阳性菌(GP)和革兰氏阴性菌(GN)病原体的 IR 分别从最低的 0.41%增加到最高的 1.15%(GP)或 1.62%(GN)。然而,GP 与 GN 的组成纵向趋势没有显示出任何显著差异(Z=±1.1918,P>0.05)。最常见的 GP 菌株是甲氧西林敏感金黄色葡萄球菌(MSSA)(17.03%)、耐甲氧西林金黄色葡萄球菌(MRSA)(10.46%)、粪肠球菌(5.19%)和表皮葡萄球菌(4.87%)。相比之下,主要 GN 菌株为铜绿假单胞菌(10.92%)、阴沟肠杆菌(10.34%)、大肠杆菌(9.47%)、鲍曼不动杆菌(7.92%)和肺炎克雷伯菌(3.33%)。一般来说,多致病菌感染的高危因素包括开放性骨折(优势比,2.223)、低蛋白血症(优势比,2.328)和多发性骨折(优势比,1.465)。值得注意的是,病原体的抗生素耐药性和敏感性分析可能会受到并发症或合并症的影响。

结论

本研究提供了中国 PTRLO 的最新数据,为临床实践提供了可靠的指导。(中国临床试验注册中心编号:ChiCTR1800017597)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/4e8fac17af13/js9-109-2721-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/c0ec46865746/js9-109-2721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/188276d4693e/js9-109-2721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/24bb64137ee3/js9-109-2721-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/4e8fac17af13/js9-109-2721-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/c0ec46865746/js9-109-2721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/188276d4693e/js9-109-2721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/24bb64137ee3/js9-109-2721-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56cf/10498838/4e8fac17af13/js9-109-2721-g006.jpg

相似文献

1
Epidemiological updates of post-traumatic related limb osteomyelitis in china: a 10 years multicentre cohort study.中国创伤后相关肢体骨髓炎的流行病学更新:一项 10 年多中心队列研究。
Int J Surg. 2023 Sep 1;109(9):2721-2731. doi: 10.1097/JS9.0000000000000502.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.针对囊性纤维化患者中耐甲氧西林金黄色葡萄球菌(MRSA)的清除干预措施。
Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD009650. doi: 10.1002/14651858.CD009650.pub5.
4
Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.用于预防外科手术患者耐甲氧西林金黄色葡萄球菌(MRSA)相关并发症的抗生素预防措施。
Cochrane Database Syst Rev. 2013 Aug 19;2013(8):CD010268. doi: 10.1002/14651858.CD010268.pub2.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.根除囊性纤维化患者体内耐甲氧西林金黄色葡萄球菌(MRSA)的干预措施。
Cochrane Database Syst Rev. 2018 Jul 21;7(7):CD009650. doi: 10.1002/14651858.CD009650.pub4.
7
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5.
8
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD003543. doi: 10.1002/14651858.CD003543.pub3.
9
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2014 Nov 10(11):CD004197. doi: 10.1002/14651858.CD004197.pub4.
10
Macrolide antibiotics (including azithromycin) for cystic fibrosis.大环内酯类抗生素(包括阿奇霉素)治疗囊性纤维化。
Cochrane Database Syst Rev. 2024 Feb 27;2(2):CD002203. doi: 10.1002/14651858.CD002203.pub5.

引用本文的文献

1
Bufei Jiedu Formula enhances CD40 activation and macrophage polarization to eliminate intracellular MRSA persisters.补肺解毒方增强CD40激活和巨噬细胞极化以清除细胞内耐甲氧西林金黄色葡萄球菌持留菌。
Front Immunol. 2025 Jul 17;16:1623182. doi: 10.3389/fimmu.2025.1623182. eCollection 2025.
2
Poly-Lysine-Derived Carbon Quantum Dots Promote the Repair of Bone Defects in Osteomyelitis Through Antibacterial and Osteogenic Effects.聚赖氨酸衍生的碳量子点通过抗菌和成骨作用促进骨髓炎骨缺损的修复。
Int J Nanomedicine. 2025 Jun 5;20:7199-7214. doi: 10.2147/IJN.S521727. eCollection 2025.
3
Management of Multidrug-Resistant Acinetobacter Infection Following Open Reduction and Internal Fixation of a Right Acetabular Fracture: A Case Report.
右髋臼骨折切开复位内固定术后耐多药不动杆菌感染的管理:一例报告
Cureus. 2025 Apr 28;17(4):e83125. doi: 10.7759/cureus.83125. eCollection 2025 Apr.
4
A three-phase strategy of bionic drug reservoir scaffold by 3D printing and layer-by-layer modification for chronic relapse management in traumatic osteomyelitis.一种用于创伤性骨髓炎慢性复发管理的通过3D打印和逐层修饰的三相仿生药物储库支架策略。
Mater Today Bio. 2024 Nov 23;29:101356. doi: 10.1016/j.mtbio.2024.101356. eCollection 2024 Dec.
5
Efficacy of pH-Responsive Surface Functionalized Titanium Screws in Treating Implant-associated S. aureus Osteomyelitis with Biofilms Formation.pH响应性表面功能化钛螺钉治疗伴有生物膜形成的种植体相关金黄色葡萄球菌骨髓炎的疗效
Adv Healthc Mater. 2025 Jan;14(3):e2403261. doi: 10.1002/adhm.202403261. Epub 2024 Nov 27.
6
Icariin-Enhanced Osteoclast-Derived Exosomes Promote Repair of Infected Bone Defects by Regulating Osteoclast and Osteoblast Communication.淫羊藿素增强的破骨细胞衍生外泌体通过调节破骨细胞和成骨细胞的通讯促进感染性骨缺损的修复。
Int J Nanomedicine. 2024 Nov 21;19:12389-12407. doi: 10.2147/IJN.S483621. eCollection 2024.
7
Borosilicate bioactive glass synergizing low-dose antibiotic loaded implants to combat bacteria through ATP disruption and oxidative stress to sequentially achieve osseointegration.硼硅酸盐生物活性玻璃协同负载低剂量抗生素的植入物,通过破坏三磷酸腺苷(ATP)和氧化应激来对抗细菌,从而依次实现骨整合。
Bioact Mater. 2024 Oct 18;44:184-204. doi: 10.1016/j.bioactmat.2024.10.009. eCollection 2025 Feb.
8
Age-related dysregulation of CXCL9/10 in monocytes is linked to impaired innate immune responses in a mouse model of Staphylococcus aureus osteomyelitis.年龄相关的 CXCL9/10 在单核细胞中的失调与金黄色葡萄球菌骨髓炎小鼠模型中先天免疫反应受损有关。
Cell Mol Life Sci. 2024 Jul 13;81(1):300. doi: 10.1007/s00018-024-05311-2.
9
Initial therapeutic evidence of a borosilicate bioactive glass (BSG) and FeO magnetic nanoparticle scaffold on implant-associated bone infection.硼硅酸盐生物活性玻璃(BSG)和FeO磁性纳米颗粒支架对种植体相关骨感染的初步治疗证据。
Bioact Mater. 2024 Jun 8;40:148-167. doi: 10.1016/j.bioactmat.2024.05.040. eCollection 2024 Oct.
10
Compassionate use of cefiderocol in a complex case of extensively drug-resistant Acinetobacter baumannii fracture-related infection: a comprehensive approach and multidisciplinary management.头孢地尔在一例广泛耐药鲍曼不动杆菌骨折相关感染复杂病例中的同情用药:综合方法与多学科管理
Infection. 2024 Dec;52(6):2487-2493. doi: 10.1007/s15010-024-02294-x. Epub 2024 May 15.